Home | Contact Us | Log In
(888) 789-6604
Report Stack
Advanced search
Account Detail 0 items in basket
Order History Total $
Saved Searches View Basket basket
Hovid Berhad (HOVID) - Financial and Strategic SWOT Analysis Review
Publication Date Jan 2014
Product Type Report
Pages 32
Single User License help $ 125.00
Site User License help $ 250.00
Corporate User License help $ 375.00
 

Reportstack.com does not charge credit card fee, transaction charges, extra tax or VAT on any purchase.

Hovid Berhad (HOVID) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Hovid Berhad (Hovid) is a pharmaceutical company. The company manufactures and commercializes pharmaceutical and herbal products. It has a portfolio of over 300 different kinds of pharmaceutical products, supplements, tocotreienols and herbal tea. Hovid also specializes in special drug delivery systems including modified release formulations and bio-availability enhanced formulations. The company offers consumer products ranging from skin care, hair care and health beverages. Its research and development activities include drug delivery systems, nanotechnology research, clinical research, product development and specialized systems.

Hovid Berhad Key Recent Developments

Feb 20, 2012: Hovid Reports Revenue Of MYR40.5m In Q2 Fiscal 2012

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Section 1 - About the Company 4
Hovid Berhad - Key Facts 4
Hovid Berhad - Key Employees 5
Hovid Berhad - Major Products and Services 6
Hovid Berhad - History 7
Hovid Berhad - Company Statement 10
Hovid Berhad - Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 14
Hovid Berhad - Business Description 14
Hovid Berhad - SWOT Analysis 15
SWOT Analysis - Overview 15
Hovid Berhad - Strengths 15
Strength - Comprehensive Product Portfolio 15
Strength - Strong Distribution Network 15
Strength - Robust Research and Development Capabilities 15
Hovid Berhad - Weaknesses 15
Weakness - Decline in Top Line Growth 15
Hovid Berhad - Opportunities 16
Opportunity - Potential in the Malaysian Healthcare Industry 16
Opportunity - Market for Generics Exports 16
Opportunity - Business Expansion 16
Hovid Berhad - Threats 17
Threat - Uncertain R&D Outcomes 17
Threat - Stringent Government Regulations 17
Threat - Intense Competitive Landscape 17
Hovid Berhad - Key Competitors 18
Section 3 – Company Financial Ratios 19
Financial Ratios - Capital Market Ratios 19
Financial Ratios - Annual Ratios 19
Performance Chart 21
Financial Performance 21
Financial Ratios - Interim Ratios 22
Financial Ratios - Ratio Charts 23
Section 4 – Company’s Lifesciences Financial Deals and Alliances 24
Hovid Berhad, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 24
Hovid Berhad, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 25
Hovid Berhad, Recent Deals Summary 26
Section 5 – Company’s Recent Developments 27
Hovid Berhad, Recent Developments 27
Feb 20, 2012: Hovid Reports Revenue Of MYR40.5m In Q2 Fiscal 2012 27
Section 6 – Appendix 28
Methodology 28
Ratio Definitions 28
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
List of Tables
Hovid Berhad, Key Facts 4
Hovid Berhad, Key Employees 5
Hovid Berhad, Major Products and Services 6
Hovid Berhad, History 7
Hovid Berhad, Subsidiaries 13
Hovid Berhad, Key Competitors 18
Hovid Berhad, Ratios based on current share price 19
Hovid Berhad, Annual Ratios 19
Hovid Berhad, Interim Ratios 22
Hovid Berhad, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 24
Hovid Berhad, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 25
Hovid Berhad, Recent Deals Summary 26
Currency Codes 28
Capital Market Ratios 28
Equity Ratios 29
Profitability Ratios 29
Cost Ratios 30
Liquidity Ratios 30
Leverage Ratios 31
Efficiency Ratios 31

List of Figures
List of Figures
Hovid Berhad, Performance Chart (2008 - 2012) 21
Hovid Berhad, Ratio Charts 23
Hovid Berhad, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 24
Hovid Berhad, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013 25

Title Date Price
2017-2022 False Lashes Report on Global and United States Market, Status and Forecast, by Players, Types and Applications
By QYResearch
This report studies the False Lashes market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in g ...Read More
Mar 2017 $2960.00
Alkem Laboratories Ltd. - Strategic SWOT Analysis Review
By GlobalData
Alkem Laboratories Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a det ...Read More
Jan 2014 $125.00
American International Industries : Consumer Packaged Goods - Company Profile, SWOT and Financial Report
By GlobalData
SynopsisCanadean's "American International Industries : Consumer Packaged Goods - Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. ...Read More
Jun 2014 $125.00
Amrutanjan Health Care Ltd. (AMRUTANJAN) - Financial and Strategic SWOT Analysis Review
By GlobalData
Amrutanjan Health Care Ltd. (AMRUTANJAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has b ...Read More
Jan 2014 $125.00
Apex Healthcare Berhad (AHEALTH) - Financial and Strategic SWOT Analysis Review
By GlobalData
Apex Healthcare Berhad (AHEALTH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been comp ...Read More
Jan 2014 $125.00
Apollo Hospitals Enterprise Limited (APOLLOHOSP) - Financial and Strategic SWOT Analysis Review
By GlobalData
Apollo Hospitals Enterprise Limited (APOLLOHOSP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profi ...Read More
Jan 2014 $125.00
Asia Sunscreen Cream Original Equipment Manufacturer (OEM) & Brands Market 2015-2021
By QYResearch
This report studies the Asia Sunscreen Cream Original Equipment Manufacturer (OEM) & Brands market, focuses on the future price trend, sales trend, and applications in Asia and major regions. Market ...Read More
Jun 2016 $3150.00
Asia-Pacific Anti Acne Cleanser Market Report 2017
By QYResearch
In this report, the Asia-Pacific Anti Acne Cleanser market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 202 ...Read More
Apr 2017 $4000.00
Asia-Pacific Anti Acne Mask Market Report 2017
By QYResearch
In this report, the Asia-Pacific Anti Acne Mask market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. ...Read More
Apr 2017 $4000.00
Asia-Pacific Body Scrub Market Report 2017
By QYResearch
In this report, the Asia-Pacific Body Scrub market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geog ...Read More
May 2017 $4000.00

  * Required field
Name *
E-mail *
Telephone 
Company *
Country *
Query 
 
   

Published By :  GlobalData

For support please
contact:
US Toll Free
+1 888-789-6604
Asia Pacific
+91-9893555190
 
 
To receive alerts about
an update, future offers and discounts on this report, signup here.
Email ID
 

Companies


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Countries


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z